Technology Transfer

Positioning Ireland as a global innovation leader in the 4th Industrial Revolution

Posted by:

Positioning Ireland as a global innovation leader in the 4th Industrial Revolution

Professor Pugatch delivered a keynote presentation at the 25th Annual Conference of the Irish Pharmaceutical Healthcare Association (IPHA) at Dublin, Ireland, themed ‘Patient Care, Powered By Innovation’.

In the field of professional boxing, Ireland was and remains a global superpower and a role model. Yet in the field of biopharmaceutical innovation, Ireland does not step into the ring of greats:

  • Despite retaining the reputation of a global leader in advances biopharmaceutical manufacturing – with €10 billion invested over the past decade – ...
Continue Reading →
0

Innovation, Intellectual Property, Market Analysis, Pharmaceuticals & Healthcare, Technology Transfer

Is Taiwan Ready for the Top Spot?

Posted by:

Is Taiwan Ready for the Top Spot?

Professor Meir Pugatch spoke today at the forum “Positioning Taiwan as an Asia-Pacific Biomedical R&D Hub” which took place the International Convention Center in Taipei, and included the Vice President of Taiwan and additional government officials.

Professor Pugatch presented a comprehensive analysis of Taiwan’s competitiveness in the biotech sector, as well as recent improvements to and remaining challenges in Taiwan’s path to leadership in global biotech innovation.

By utilizing a competitive mentality that views policy as instrumental in achieving economic and societal ...

Continue Reading →
0

Innovation, Intellectual Property, Market Analysis, Pharmaceuticals & Healthcare, Technology Transfer

To SPC or not to SPC…

Posted by:

To SPC or not to SPC…

Does the EU Commission really think weakening IP incentives for biopharmaceutical innovation in Europe is going to create more jobs and economic activity?

by Dr David Torstensson, Partner, Pugatch Consilium

As an industry the research-based biopharmaceutical sector is one of Europe’s biggest success stories. Companies like Novartis, Roche, Sanofi Aventis, Novo Nordisk, AstraZeneca and GSK are some of the largest, most innovative and successful research-based biopharmaceutical companies in the world. Not only do these companies have a long track record of producing ...

Continue Reading →
0

Intellectual Property, Market Analysis, Pharmaceuticals & Healthcare, Technology Transfer

The US Chamber of Commerce and Pugatch Consilium’s Dr David Torstensson launch 2nd edition of the GIPC IP Index

Posted by:

The US Chamber of Commerce and Pugatch Consilium’s Dr David Torstensson launch 2nd edition of the GIPC IP Index

Dr David Torstensson, Partner with Pugatch Consilium, is speaking at the international launch of the 2013 GIPC IP Index at the US Chamber of Commerce in Washington DC, USA. Pugatch Consilium has developed the GIPC IP Index in partnership with the US Chamber of Commerce’s Global Intellectual Property Center. The Index is a one-of-a-kind instrument that benchmarks and measures the national IP environment in 25 countries.

The launch of the 2013 Index will take place on January 29 2014 starting at ...

Continue Reading →
0

Innovation, Intellectual Property, Market Analysis, Technology Transfer

Bridging the gap?

Posted by:

Bridging the gap?

The European Patent Office and China’s State Intellectual Property Office have agreed to ensure that the public has access to automatic Chinese-English translation tools for patents. They have pledged to make this free, online service available by next year.

With many of 2010’s 1.8 million patent fillings stemming from China and Europe, this move will no doubt facilitate the ability to follow technical developments and share know-how on a global scale.

But will this actually mean greater, high value transfer of technology ...

Continue Reading →
0

Innovation, Intellectual Property, Technology Transfer

From compulsory licensing to voluntary transfer?

Posted by:

From compulsory licensing to voluntary transfer?

Bristol-Myers Squibb announced a technology transfer agreement with the Brazilian Ministry of Health to expand access to the HIV drug atazanavir. The agreement is designed to build the capacity and skills required for the Brazilian government to become, over time, the sole manufacturer of atazanavir in Brazil.

Does this mark a shift in Brazil’s HIV/AIDS pharmaceutical policy, which in the past was marked by aggressive negotiation with manufacturers and threats of compulsory licensing?

For further details, see:

http://www.news-medical.net/news/20111113/Brazilian-Ministry-of-Health-Bristol-Myers-Squibb-sign-technology-transfer-agreement-for-Reyataz.aspx

http://www.ntn24.com/news/news/brazil-start-producing-anti-hiv-drug

 

Continue Reading →
0

Intellectual Property, Pharmaceuticals & Healthcare, Technology Transfer

China turning up the heat?

Posted by:

China turning up the heat?

International R&D collaboration is on the rise as China sets out to meet its smart grid goals.

French energy company Alstom signs a new R&D partnership with CET, a subsidiary of China’s State Grid Corporation and one of the largest electrical equipment companies in China. Under the terms of the agreement, CET and Alstom will cooperate on the development and manufacture of key technologies for future ultra high voltage electrical grids.

Is this a signal that China’s R&D efforts will become increasingly ...

Continue Reading →
0

Energy & Environmentally Sound Technologies, Innovation, Technology Transfer